Dapagliflozin Effect on Hospital Admissions in Patients With CKD: A Post Hoc Analysis of the DAPA-CKD Trial

被引：0
|
作者：
Schechter, Meir [1 ,7 ]
Jongs, Niels [1 ]
Chertow, Glenn [2 ]
Mosenzon, Ofri [7 ,11 ]
McMurray, John [3 ]
Correa-Rotter, Ricardo [4 ]
Rossing, Peter [5 ]
Langkilde, Anna Maria [6 ]
Sjostrom, David [6 ]
Toto, Robert D. [8 ]
Wheeler, David C. [9 ]
Heerspink, Hiddo J. L. [1 ,10 ]
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
[2] Stanford Univ, Sch Med, Stanford, CA USA
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico
[5] Steno Diabet Ctr Copenhagen, Herlev, Denmark
[6] AstraZeneca, BioPharmaceut R&D, Gothenburg, Sweden
[7] Hadassah Univ, Med Ctr, Jerusalem, Israel
[8] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA
[9] UCL, Fac Med Sci, London, England
[10] George Inst Global Hlth, Newtown, NSW, Australia
[11] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-OR26
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [1] Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease: A Post Hoc Analysis of DAPA-CKD
    Schechter, Meir
    Jongs, Niels
    Chertow, Glenn M.
    Mosenzon, Ofri
    McMurray, John J., V
    Correa-Rotter, Ricardo
    Rossing, Peter
    Langkilde, Anna Maria
    Sjostrom, C. David
    Toto, Robert D.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (01) : 59 - +
  • [2] The Effect of Dapagliflozin on Rate of Kidney Function Decline in Patients with CKD: A Prespecified Analysis from the DAPA-CKD Trial
    Heerspink, Hiddo J. L.
    Jongs, Niels
    Chertow, Glenn M.
    Langkilde, Anna Maria
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur V.
    Toto, Robert D.
    Wheeler, David C.
    Greene, Tom
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 35 - 36
  • [3] Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
    Waijer, Simke W.
    Vart, Priya
    Cherney, David Z., I
    Chertow, Glenn M.
    Jongs, Niels
    Langkilde, Anna Maria
    Mann, Johannes F. E.
    Mosenzon, Ofri
    McMurray, John J., V
    Rossing, Peter
    Correa-Rotter, Ricardo
    Stefansson, Bergur, V
    Toto, Robert D.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    DIABETOLOGIA, 2022, 65 (07) : 1085 - 1097
  • [4] Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
    Simke W. Waijer
    Priya Vart
    David Z. I. Cherney
    Glenn M. Chertow
    Niels Jongs
    Anna Maria Langkilde
    Johannes F. E. Mann
    Ofri Mosenzon
    John J. V. McMurray
    Peter Rossing
    Ricardo Correa-Rotter
    Bergur V. Stefansson
    Robert D. Toto
    David C. Wheeler
    Hiddo J. L. Heerspink
    Diabetologia, 2022, 65 : 1085 - 1097
  • [5] Efficacy and Safety of Dapagliflozin by Glycemic Status in the DAPA-CKD Trial
    Persson, Frederik
    Rossing, Peter
    Vart, Priya
    Chertow, Glenn M.
    Hou, Fan Fan
    McMurray, John J.
    Correa-Rotter, Ricardo
    Bajaj, Harpreet S.
    Stefansson, Bergur
    Toto, Robert D.
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo L.
    DIABETES, 2021, 70
  • [6] Efficacy and Safety of Dapagliflozin by Glycemic Status in the DAPA-CKD Trial
    Persson, Frederik
    Rossing, Peter
    Vart, Priya
    Chertow, Glenn M.
    Hou, Fan Fan
    McMurray, John J.
    Correa-Rotter, Ricardo
    Bajaj, Harpreet S.
    Stefansson, Bergur
    Toto, Robert D.
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo L.
    DIABETES, 2021, 70
  • [7] Effects of Dapagliflozin in Patients Without Diabetes and Microalbuminuria: An Exploratory Analysis From the DAPA-CKD Trial
    Heerspink, Hiddo J. L.
    Chertow, Glenn
    Jongs, Niels
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, David
    Langkilde, Anna Maria
    Wheeler, David C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 847 - 848
  • [8] Effects of Dapagliflozin on Anemia in Patients With CKD With or Without Type 2 Diabetes: A Pre-Specified Analysis of the DAPA-CKD Trial
    Heerspink, Hiddo J. L.
    Koshino, Akihiko
    Schechter, Meir
    Vart, Priya
    Jongs, Niels
    Chertow, Glenn
    Toto, Robert D.
    Rossing, Peter
    Correa-Rotter, Ricardo
    McMurray, John
    Langkilde, Anna Maria
    Wheeler, David C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 43 - 43
  • [9] Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial
    Persson, Frederik
    Rossing, Peter
    Vart, Priya
    Chertow, Glenn M.
    Hou, Fan Fan
    Jongs, Niels
    McMurray, John J., V
    Correa-Rotter, Ricardo
    Bajaj, Harpreet S.
    Stefansson, Bergur, V
    Toto, Robert D.
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    DIABETES CARE, 2021, 44 (08) : 1894 - 1897
  • [10] Effects of Dapagliflozin in Patients with CKD and Albuminuria, with and Without Diabetes, by Use and Non-Use of Cardiovascular Medications: DAPA-CKD Trial
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Mark, Patrick B.
    Nowicki, Michal P.
    Vart, Priya
    Jongs, Niels
    Langkilde, Anna Maria
    McMurray, John
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur V.
    Toto, Robert D.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 725 - 725
12345